|
|
Accelerator Nordic Ab - Comparative Business Analysis Snapshot
Business Description
Accelerator Nordic Ab Formerly known as Accelerator I Linkoping AB. The Group's principal activity is investing in different development companies in Life Sciences. Among the Groups holdings are Pledpharma AB which develops new pharmaceutical applications from clinically approved Pled-derivative and OptoQ AB which markets and sells systems and technology platforms for sage and cost-effective patient monitoring.
Competitor Analysis
This analysis compares Accelerator Nordic Ab with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
